They're not looking at the bigger picture; they're just looking at dollar signs. I don't want to be labeled as a dollar sign.

We came across a bullish thesis on REGENXBIO Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls ...

For more than 10 years, Napa in Newport has been the signature event to raise funds and awareness for CureDuchenne, a Newport ...

US FDA grants Orphan Drug Designation to Atossa Therapeutics’ (Z)-endoxifen to treat Duchenne muscular dystrophy: Seattle Monday, January 19, 2026, 17:00 Hrs [IST] Atossa Therap ...

As biotechs faced investors at the J.P. Morgan Healthcare Conference this week, they emphasized agreement with the FDA on ...